BridgeBio Pharma EPS - Earnings per Share 2018-2024 | BBIO

BridgeBio Pharma earnings per share (EPS) for the twelve months ending December 31, 2024 was $-2.88, a 27.09% decline year-over-year.

  • BridgeBio Pharma EPS for the quarter ending December 31, 2024 was $-1.43, a 47.42% increase year-over-year.
  • BridgeBio Pharma 2024 annual EPS was $-2.88, a 27.09% decline from 2023.
  • BridgeBio Pharma 2023 annual EPS was $-3.95, a 21.17% increase from 2022.
  • BridgeBio Pharma 2022 annual EPS was $-3.26, a 16.41% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

BridgeBio Pharma EPS - Earnings per Share 2018-2024 | BBIO

  • BridgeBio Pharma EPS for the quarter ending December 31, 2024 was $-1.43, a 47.42% increase year-over-year.
  • BridgeBio Pharma 2024 annual EPS was $-2.88, a 27.09% decline from 2023.
  • BridgeBio Pharma 2023 annual EPS was $-3.95, a 21.17% increase from 2022.
  • BridgeBio Pharma 2022 annual EPS was $-3.26, a 16.41% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$11.2B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M